• Medtronic completed its acquisition of privately held Scientia Vascular for USD 550 million, subject to customary adjustments, with potential undisclosed earn-outs.
• Scientia, based in Salt Lake City, makes neurovascular access devices; its guidewires and catheters will be integrated into Medtronic’s neurovascular portfolio.
• The deal expands Medtronic’s neurovascular platform, targeting faster, more reliable access in complex cerebral anatomy to improve procedural efficiency.
• The acquisition is expected to be minimally dilutive to adjusted EPS in FY27, turning accretive thereafter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606121100PR_NEWS_USPR_____CG82150) on June 12, 2026, and is solely responsible for the information contained therein.